These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1614 related items for PubMed ID: 32197467

  • 1. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA, Chang HL, Ong JR, Lee WH, Yeh CT, Tsai JT.
    Cells; 2020 Mar 18; 9(3):. PubMed ID: 32197467
    [Abstract] [Full Text] [Related]

  • 2. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M, Liu S, Chua MS, Li H, Luo D, Wang S, Zhang S, Han B, Sun C.
    Cell Death Dis; 2019 Aug 13; 10(8):612. PubMed ID: 31406106
    [Abstract] [Full Text] [Related]

  • 3. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.
    Chen MY, Hsu CH, Setiawan SA, Tzeng DTW, Ma HP, Ong JR, Chu YC, Hsieh MS, Wu ATH, Tzeng YM, Yeh CT.
    Phytomedicine; 2023 Jan 13; 108():154478. PubMed ID: 36265255
    [Abstract] [Full Text] [Related]

  • 4. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
    Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y.
    Cell Death Dis; 2013 Oct 24; 4(10):e875. PubMed ID: 24157869
    [Abstract] [Full Text] [Related]

  • 5. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR, Joshi S, Burgoyne AM, Sicklick JK, Ikeda S, Kono Y, Garlich JR, Morales GA, Durden DL.
    Mol Cancer Ther; 2016 Nov 24; 15(11):2553-2562. PubMed ID: 27496136
    [Abstract] [Full Text] [Related]

  • 6. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H, Liu Q, Tang J, Xie Y, Xu X, Huang R, Zhang Y, Jin K, Sun B.
    Cell Physiol Biochem; 2017 Nov 24; 41(6):2289-2306. PubMed ID: 28456796
    [Abstract] [Full Text] [Related]

  • 7. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y, Zheng Q, Dong Y, Xie X, Wang Y, Wu S, Zhang L, Wang Y, Xue T, Wang Z, Chen R, Wang Y, Cui J, Ren Z.
    Oncotarget; 2016 May 31; 7(22):32221-31. PubMed ID: 27050147
    [Abstract] [Full Text] [Related]

  • 8. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.
    Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y.
    Bioengineered; 2021 Dec 31; 12(2):9162-9173. PubMed ID: 34696683
    [Abstract] [Full Text] [Related]

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 31; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 10. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX, Shi WN, Song ZY, Wang SQ, Yu XF, Gao ZH, Qu XJ.
    Oncotarget; 2016 Jun 14; 7(24):36767-36782. PubMed ID: 27167344
    [Abstract] [Full Text] [Related]

  • 11. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
    Zhang X, Shao J, Li X, Cui L, Tan Z.
    Oncol Rep; 2019 Feb 14; 41(2):1067-1074. PubMed ID: 30483804
    [Abstract] [Full Text] [Related]

  • 12. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
    Li L, Liu JD, Gao GD, Zhang K, Song YW, Li HB.
    Cancer Med; 2020 Sep 14; 9(17):6399-6410. PubMed ID: 32691991
    [Abstract] [Full Text] [Related]

  • 13. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y.
    Int J Biochem Cell Biol; 2013 Dec 14; 45(12):2736-48. PubMed ID: 24076216
    [Abstract] [Full Text] [Related]

  • 14. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
    Liu C, Peng X, Li Y, Liu S, Hou R, Zhang Y, Zuo S, Liu Z, Luo R, Li L, Fang W.
    Biomed Pharmacother; 2020 Mar 14; 123():109780. PubMed ID: 31901550
    [Abstract] [Full Text] [Related]

  • 15. Coptisine induces autophagic cell death through down-regulation of PI3K/Akt/mTOR signaling pathway and up-regulation of ROS-mediated mitochondrial dysfunction in hepatocellular carcinoma Hep3B cells.
    Kim SY, Hwangbo H, Kim MY, Ji SY, Lee H, Kim GY, Kwon CY, Leem SH, Hong SH, Cheong J, Choi YH.
    Arch Biochem Biophys; 2021 Jan 15; 697():108688. PubMed ID: 33227289
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, Li Y.
    BMC Cancer; 2019 Jun 24; 19(1):618. PubMed ID: 31234823
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of microRNA-133b is associated with the increased survival of patients with hepatocellular carcinoma after curative hepatectomy: Involvement of the EGFR/PI3K/Akt/mTOR signaling pathway.
    Wang X, Zeng J, Wang L, Zhang X, Liu Z, Zhang H, Dong J.
    Oncol Rep; 2017 Jul 24; 38(1):141-150. PubMed ID: 28586051
    [Abstract] [Full Text] [Related]

  • 18. PDK1 is a potential therapeutic target against angiosarcoma cells.
    Wada M, Horinaka M, Yasuda S, Masuzawa M, Sakai T, Katoh N.
    J Dermatol Sci; 2015 Apr 24; 78(1):44-50. PubMed ID: 25726712
    [Abstract] [Full Text] [Related]

  • 19. Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress.
    Thompson SM, Callstrom MR, Jondal DE, Butters KA, Knudsen BE, Anderson JL, Lien KR, Sutor SL, Lee JS, Thorgeirsson SS, Grande JP, Roberts LR, Woodrum DA.
    PLoS One; 2016 Apr 24; 11(9):e0162634. PubMed ID: 27611696
    [Abstract] [Full Text] [Related]

  • 20. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway.
    Luo Y, Wang Z, Jiang J, Wu S, Zhai Y.
    Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.